• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[作为脊髓中决定性结构的病理性增强兴奋的产生器]

[Generators of pathologically enhanced excitation as determinant structures in the spinal cord].

作者信息

Kryzhanovskiĭ G N, Grafova V N, Danilova E I

出版信息

Biull Eksp Biol Med. 1977 May;83(5):515-9.

PMID:884247
Abstract

Using tetanus toxin as a tool to disturb the inhibition, enhanced excitation generators were created in the anterior horns of lumbar segments of the left and right sides of albino rat spinal cord. The generators worked at different regimens: the "left-side" generator originating under conditions of a more prolonged toxin action, on being activated by trigger stimulation, produced first tonic and then intermittent activity or periodic spontaneous discharges; the "right-side" generator produced only tonic activity. After the inhibition of one of the generators by glycine the other continued working in its regimen. Activation of one of the generators was followed by inhibition of the effect of the other. In case of separate activation of one of the generators all pools of the spinal and supraspinal motor neurons reproduced the activity pattern of the generator working at that moment. Thus, the latter played the role of the hyperactive structure determining the system behaviour, i.e. the determinant. The evidence obtained is analyzed from the point of view of the general concept on the role of the determinant structures in the nervous system activity and the theory of generator mechanisms of the neuropathological syndromes characterized by the system hyperactivity.

摘要

利用破伤风毒素作为干扰抑制作用的工具,在白化大鼠脊髓左右两侧腰段前角中产生了增强的兴奋发生器。这些发生器以不同的方式工作:“左侧”发生器在毒素作用时间更长的条件下产生,在触发刺激激活时,首先产生强直性活动,然后是间歇性活动或周期性自发放电;“右侧”发生器仅产生强直性活动。在用甘氨酸抑制其中一个发生器后,另一个仍按其方式继续工作。激活其中一个发生器后,另一个发生器的效应会受到抑制。如果单独激活其中一个发生器,脊髓和脊髓上运动神经元的所有池都会重现当时工作的发生器的活动模式。因此,后者起到了决定系统行为的多动结构的作用,即决定因素。从关于决定因素结构在神经系统活动中的作用的一般概念以及以系统多动为特征的神经病理综合征的发生器机制理论的角度,对所获得的证据进行了分析。

相似文献

1
[Generators of pathologically enhanced excitation as determinant structures in the spinal cord].[作为脊髓中决定性结构的病理性增强兴奋的产生器]
Biull Eksp Biol Med. 1977 May;83(5):515-9.
2
[Prolongation of sleep following creation of a generator of pathologically enhanced excitation in the orbital cortex].
Biull Eksp Biol Med. 1977 Nov;84(11):531-4.
3
[Theory of generator mechanisms in several neuropathologic syndrome].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1976;76(11):1730-40.
4
[Modeling neuropathologic syndromes by creating generators of pathologically enhanced excitation in the hypothalamus of rabbits].[通过在兔下丘脑创建病理性增强兴奋的发生器来模拟神经病理综合征]
Biull Eksp Biol Med. 1977 Oct;84(10):405-8.
5
[Intercentral relations in rat spinal cord with local depression of the inhibitory processes].
Neirofiziologiia. 1975;7(3):234-42.
6
[Effect of antiepileptic agents in myoclonus of spinal origin].
Biull Eksp Biol Med. 1980 Nov;90(11):538-41.
7
[Neuropathologic effects developing after administration of tetanus toxin to several rat brain structures].
Biull Eksp Biol Med. 1979 Feb;87(2):124-6.
8
[Experimental pain and pruritic syndromes of thalamic origin].
Biull Eksp Biol Med. 1976 Jun;81(6):651-3.
9
[Effect of a generator of pathologically intensified excitation in the orbital cortex on the sleep--wakefulness cycle].
Zh Vyssh Nerv Deiat Im I P Pavlova. 1978 Jul-Aug;28(4):782-91.
10
[Asymmetric distribution of peptide regulators of muscle tonus and substance P in the spinal cord of rats with unilateral hyperactivity of the lumbar enlargement neurons].
Biull Eksp Biol Med. 1987 Dec;104(12):657-60.

引用本文的文献

1
Rhythmic activity in the cerebellum and spinal cord of rabbits receiving tetanus toxin intravenously.静脉注射破伤风毒素的家兔小脑和脊髓中的节律性活动。
Naunyn Schmiedebergs Arch Pharmacol. 1981 Aug;317(1):51-3. doi: 10.1007/BF00506256.